Loading...

Nanomaterials for photocatalytic degradations of analgesic, mucolytic and anti-biotic/viral/inflammatory drugs widely used in controlling sars-CoV-2

Ebrahimi, M ; Sharif University of Technology | 2022

34 Viewed
  1. Type of Document: Article
  2. DOI: 10.3390/catal12060667
  3. Publisher: MDPI , 2022
  4. Abstract:
  5. The COVID-19 pandemic has been transformed into one of the main worldwide chal-lenges, in recent years. For controlling symptoms that are caused by this disease (e.g., chills or fever, shortness of breath and/or difficulty in breathing, cough, sore throat, fatigue, headache, muscle aches, the new loss of tastes and/or smells, congestion or runny nose, nausea, vomiting and/or diar-rhea), lots of medicines including analgesics, mucolytics, and anti-biotic/viral/inflammatory drugs have been frequently prescribed. As these medicines finally contaminate terrestrial and aquatic hab-itats by entering surface waterways through pharmaceutical production and excreting trace amounts of waste after human usage, they have negative impacts on wildlife’s health and ecosys-tem. Residual drugs in water have the potential to harm aquatic creatures and disrupt their food chain as well as the breeding cycle. Therefore, proper degradation of these broadly used medicines is highly crucial. In this work, the use of nanomaterials applicable in photocatalytic degradations of analgesics (e.g., acetaminophen, aspirin, ibuprofen, and naproxen), mucolytics (e.g., ambroxol), antibiotics (e.g., azithromycin and quinolones including hydroxychloroquine and chloroquine phos-phate), anti-inflammatory glucocorticoids (e.g., dexamethasone and cortisone acetate), antihistamines (e.g., diphenhydramine), H2 blockers (e.g., famotidine), anthelmintics (e.g., praziquantel), and finally antivirals (e.g., ivermectin, acyclovir, lopinavir/ritonavir, favipiravir, nitazoxanide, and remdesivir) which widely used in controlling/treating the coronavirus have been reviewed and dis-cussed. © 2022 by the authors. Licensee MDPI, Basel, Switzerland
  6. Keywords:
  7. Antibiotics, antiviral drugs ; Catalysts ; Covid-19 ; Nanomaterials ; Pharmaceutical wastes
  8. Source: Catalysts ; Volume 12, Issue 6 , 2022 ; 20734344 (ISSN)
  9. URL: https://www.mdpi.com/2073-4344/12/6/667